Miao-Miao Niu (Miaomiao Niu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Molecular Docking

Radical Prostatectomy

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

Advanced healthcare materials

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Lufeng Zheng, Yuxin Zhang, Shuang Mei, Tianyuan Xie, Yunting Zou, Yuting Wang, Han Jing, Shengtao Xu, Pierre Dramou, Zhen Xu, Jindong Li, Yang Zhou, Miao-Miao Niu
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer. Journal of medicinal chemistry 67 (9) (2024)
Lufeng Zheng, Yuxin Zhang, Shuang Mei, Tianyuan Xie, Yunting Zou, Yuting Wang, Han Jing, Shengtao Xu, Pierre Dramou, Zhen Xu, Jindong Li, Yang Zhou, Miao-Miao Niu
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer. Journal of medicinal chemistry (2024)
Lufeng Zheng, Yunting Zou, Tianyuan Xie, Xiuyuan Wu, Yuchen Tan, Shuang Mei, Yifei Geng, Shutong Chen, Shengtao Xu, Miao-Miao Niu
Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation. Journal of medicinal chemistry 66 (23) (2023)
Yin Yuan, Hong Yao, Manzhen Zhou, Xiaoqian Ma, Yi Zhou, Jinyi Xu, Miao-Miao Niu, Jun Yin, Lufeng Zheng, Shengtao Xu
Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization. Journal of medicinal chemistry 65 (23) (2022)
Yunjiang Zhou, Yunting Zou, Mei Yang, Shuang Mei, Xiaohao Liu, Huiyun Han, Chang-Dong Zhang, Miao-Miao Niu
Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer. Journal of the American Chemical Society 144 (16) (2022)
Lufeng Zheng, Ren Ren, Xiaolian Sun, Yunting Zou, Yiru Shi, Bin Di, Miao-Miao Niu
Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation. Journal of medicinal chemistry 64 (21) (2021)
Yunjiang Zhou, Yaxin Chen, Xing Huang, Yingying Tan, Rong Hu, Chong Li, Miao-Miao Niu
A Supramolecular Nanomedicine Based on Bendamustine and MDM2-Targeted D-peptide Inhibitor for Breast Cancer Therapy. Advanced healthcare materials 10 (21) (2021)
Yunjiang Zhou, Yaxin Chen, Yingying Tan, Rong Hu, Miao-Miao Niu
An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy. Advanced healthcare materials 10 (9) (2021)
Fang Yan, Guangmei Liu, Tingting Chen, Xiaochen Fu, Miao-Miao Niu
Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain. Molecules (Basel, Switzerland) 25 (1) (2019)
Yunjiang Zhou, Fang Yan, Xiangyun Huo, Miao-Miao Niu
Discovery of a Potent PLK1-PBD Small-Molecule Inhibitor as an Anticancer Drug Candidate through Structure-Based Design. Molecules (Basel, Switzerland) 24 (23) (2019)
Yunjiang Zhou, Bin Di, Miao-Miao Niu
Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity. Molecules (Basel, Switzerland) 24 (17) (2019)
Yunjiang Zhou, Shi Tang, Tingting Chen, Miao-Miao Niu
Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors. Molecules (Basel, Switzerland) 24 (23) (2019)